Anticorps Polyclonal de lapin anti-Arginase-1
Arginase-1 Polyclonal Antibody for WB, IHC, IF/ICC, IF-P, IP, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat, souris et plus (2)
Applications
WB, IHC, IF/ICC, IF-P, IP, CoIP, ELISA
Conjugaison
Non conjugué
N° de cat : 16001-1-AP
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | tissu hépatique de souris, tissu hépatique de rat |
| Résultats positifs en IP | tissu hépatique de souris, |
| Résultats positifs en IHC | tissu de cancer du foie humain, tissu hépatique de souris il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0. |
| Résultats positifs en IF-P | tissu hépatique de souris, tissu de cancer du foie humain |
| Résultats positifs en IF/ICC | cellules HepG2, |
Dilution recommandée
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:5000-1:50000 |
| Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochimie (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)-P | IF-P : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| WB | See 383 publications below |
| IHC | See 75 publications below |
| IF | See 216 publications below |
| CoIP | See 1 publications below |
Informations sur le produit
16001-1-AP cible Arginase-1 dans les applications de WB, IHC, IF/ICC, IF-P, IP, CoIP, ELISA et montre une réactivité avec des échantillons Humain, rat, souris
| Réactivité | Humain, rat, souris |
| Réactivité citée | rat, bovin, Humain, porc, souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Polyclonal |
| Type | Anticorps |
| Immunogène | Arginase-1 Protéine recombinante Ag8595 |
| Nom complet | arginase, liver |
| Masse moléculaire calculée | 236aa,25 kDa; 322aa,35 kDa |
| Poids moléculaire observé | 35-36 kDa |
| Numéro d’acquisition GenBank | BC005321 |
| Symbole du gène | Arginase-1 |
| Identification du gène (NCBI) | 383 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par affinité contre l'antigène |
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
Arginase-1 (Liver arginase) belongs to the arginase family. ARG1 is a novel immunohistochemical marker of hepatocellular differentiation in fine needle aspiration cytology and a marker of hepatocytes and hepatocellular neoplasms. ARG1 is closely associated with alternative macrophage activation and ARG1 has been shown to protect motor neurons from trophic factor deprivation and allow sensory neurons to overcome neurite outgrowth inhibition by myelin proteins (PMID: 20071539, PMID:12098359). It can exist as a homotrimer and has 3 isoforms produced by alternative splicing (PMID:16141327). Defects in ARG1 are the cause of argininemia (ARGIN). Deletion or TNF-mediated restriction of ARG1 unleashes the production of NO by NOS2, which is critical for pathogen control (PMID:27117406). ARG1 is mainly expresses in neurons in a normal brain. The expression of ARG1 increases in microglia/macrophages and astrocytes early after CNS injuries. ARG1 has been regarded as a marker for beneficial microglia/macrophages and possesses anti-inflammatory and tissue repair properties under various pathological conditions (PMID: 26538310, PMID: 31619589).
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for Arginase-1 antibody 16001-1-AP | Download protocol |
| IHC protocol for Arginase-1 antibody 16001-1-AP | Download protocol |
| IF protocol for Arginase-1 antibody 16001-1-AP | Download protocol |
| IP protocol for Arginase-1 antibody 16001-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
| Species | Application | Title |
|---|---|---|
Adv Mater Realizing Highly Efficient Sonodynamic Bactericidal Capability through the Phonon-Electron Coupling Effect Using Two-Dimensional Catalytic Planar Defects | ||
Sci Transl Med An extracorporeal bioartificial liver embedded with 3D-layered human liver progenitor-like cells relieves acute liver failure in pigs. | ||
Adv Sci (Weinh) Material Stiffness in Cooperation with Macrophage Paracrine Signals Determines the Tenogenic Differentiation of Mesenchymal Stem Cells | ||
Biomaterials Implantation of MSC spheroid-derived 3D decellularized ECM enriched with the MSC secretome ameliorates traumatic brain injury and promotes brain repair | ||
Sci Adv Bioactive fiber-reinforced hydrogel to tailor cell microenvironment for structural and functional regeneration of myotendinous junction | ||
Theranostics Multifunctionally disordered TiO2 nanoneedles prevent periprosthetic infection and enhance osteointegration by killing bacteria and modulating the osteoimmune microenvironment |
Avis
The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.
FH Debanjan (Verified Customer) (12-23-2019) | This antibody performs very well for immunohistochemistry from human skin samples
![]() |









